GlassScriptPhysician profile
Amanda C Mcdonagh
NPI 1114580495
$2,872.33
in general payments reported to CMS, 2019-2025
17 companies · $534 in 2025
The $534 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.00 · 2022: $80.62 · 2023: $193 · 2024: $2,004 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,829 · Food and Beverage: $876 · Education: $25.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,829.24 |
| Food and Beverage | $876.16 |
| Education | $25.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,858.22 | 2024-2025 | |
| Novo Nordisk INC | $180.33 | 2021-2025 | Wegovy |
| Medtronic, INC. | $168.54 | 2023-2024 | V-Loc 180, Signia |
| Davol INC. | $147.59 | 2024-2025 | Phasix Mesh |
| Phathom Pharmaceuticals, INC. | $111.65 | 2024-2025 | Voquezna |
| Boston Scientific Corporation | $98.52 | 2023-2025 | Spyglass Discover, Overstitch Nxt Endoscopic Suturing System |
| Lilly USA, LLC | $75.79 | 2024 | Zepbound, Jardiance |
| Integra Lifesciences Corporation | $35.08 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axonics, INC. | $32.60 | 2021 | |
| Heron Therapeutics, INC. | $30.13 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.13 | 2023 | Gattex |
| Biotissue Holdings INC. | $22.46 | 2024 | |
| Baxter Healthcare | $17.48 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $17.30 | 2025 | |
| Braintree Laboratories, INC. | $17.21 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $17.13 | 2024 | Ovitex 2s |
| Olympus America INC. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mcdonagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.